Research Paper Volume 15, Issue 16 pp 8155—8184
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
Figure 12. Gene-drug interaction and drug sensitivity analysis. (A) Relationship between RP2 expression and drug sensitivity in the GSCA database. (B) CTD showed the network of action between RP2 and drugs or small molecules. (C) Drug susceptibility results from three databases were displayed.